Tower Bridge Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.4M | Buy |
27,200
+1,075
| +4% | +$583K | 1.29% | 19 |
|
|
2025
Q4 | $15.1M | Sell |
26,125
-280
| -1% | -$158K | 1.53% | 15 |
|
|
2025
Q3 | $12.8M | Sell |
26,405
-119
| -0.4% | -$55.4K | 1.28% | 19 |
|
|
2025
Q2 | $10.8M | Buy |
26,524
+1,368
| +5% | +$572K | 1.16% | 23 |
|
|
2025
Q1 | $12.5M | Sell |
25,156
-42
| -0.2% | -$22.7K | 1.4% | 19 |
|
|
2024
Q4 | $13.1M | Sell |
25,198
-145
| -0.6% | -$79.7K | 1.4% | 17 |
|
|
2024
Q3 | $15.7M | Buy |
25,343
+184
| +0.7% | +$109K | 1.63% | 15 |
|
|
2024
Q2 | $13.9M | Sell |
25,159
-2,961
| -11% | -$1.7M | 1.55% | 15 |
|
|
2024
Q1 | $16.3M | Sell |
28,120
-4,680
| -14% | -$2.63M | 1.66% | 15 |
|
|
2023
Q4 | $17.4M | Sell |
32,800
-246
| -0.7% | -$119K | 1.5% | 15 |
|
|
2023
Q3 | $16.7M | Buy |
33,046
+155
| +0.5% | +$82.6K | 1.55% | 16 |
|
|
2023
Q2 | $17.2M | Sell |
32,891
-13,216
| -29% | -$7.13M | 1.57% | 16 |
|
|
2023
Q1 | $26.6M | Sell |
46,107
-1,003
| -2% | -$565K | 2.18% | 9 |
|
|
2022
Q4 | $25.9M | Buy |
47,110
+348
| +0.7% | +$184K | 2.15% | 7 |
|
|
2022
Q3 | $23.7M | Sell |
46,762
-111
| -0.2% | -$62.1K | 2.11% | 7 |
|
|
2022
Q2 | $25.5M | Sell |
46,873
-1,180
| -2% | -$649K | 2.08% | 9 |
|
|
2022
Q1 | $28.4M | Sell |
48,053
-243
| -0.5% | -$140K | 1.9% | 9 |
|
|
2021
Q4 | $32.2M | Buy |
48,296
+633
| +1% | +$395K | 1.98% | 7 |
|
|
2021
Q3 | $27.2M | Buy |
47,663
+1,351
| +3% | +$741K | 1.82% | 10 |
|
|
2021
Q2 | $23.4M | Buy |
46,312
+9,998
| +28% | +$4.72M | 1.56% | 14 |
|
|
2021
Q1 | $16.6M | Buy |
36,314
+1,235
| +4% | +$589K | 1.25% | 22 |
|
|
2020
Q4 | $16.3M | Buy |
35,079
+7,570
| +28% | +$3.55M | 1.33% | 22 |
|
|
2020
Q3 | $12.1M | Sell |
27,509
-230
| -0.8% | -$95K | 1.24% | 27 |
|
|
2020
Q2 | $10.1M | Sell |
27,739
-365
| -1% | -$122K | 1.13% | 31 |
|
|
2020
Q1 | $7.97M | Sell |
28,104
-40
| -0.1% | -$12.6K | 1.05% | 34 |
|
|
2019
Q4 | $9.14M | Sell |
28,144
-3,870
| -12% | -$1.17M | 0.97% | 39 |
|
|
2019
Q3 | $9.43M | Sell |
32,014
-330
| -1% | -$94.5K | 1.03% | 35 |
|
|
2019
Q2 | $9.5M | Sell |
32,344
-85
| -0.3% | -$23.4K | 1.06% | 31 |
|
|
2019
Q1 | $8.88M | Buy |
32,429
+90
| +0.3% | +$22.4K | 1.03% | 35 |
|
|
2018
Q4 | $7.24M | Buy |
32,339
+495
| +2% | +$116K | 0.93% | 40 |
|
|
2018
Q3 | $7.77M | Sell |
31,844
-70
| -0.2% | -$16.1K | 0.81% | 46 |
|
|
2018
Q2 | $6.61M | Buy |
31,914
+600
| +2% | +$127K | 0.74% | 48 |
|
|
2018
Q1 | $6.47M | Buy |
31,314
+6,950
| +29% | +$1.46M | 0.72% | 53 |
|
|
2017
Q4 | $4.63M | Buy |
24,364
+1,845
| +8% | +$353K | 0.5% | 66 |
|
|
2017
Q3 | $4.26M | Buy |
22,519
+1,100
| +5% | +$199K | 0.48% | 65 |
|
|
2017
Q2 | $3.74M | Buy |
21,419
+150
| +0.7% | +$25.2K | 0.43% | 71 |
|
|
2017
Q1 | $3.27M | Hold |
21,269
| – | – | 0.38% | 75 |
|
|
2016
Q4 | $3M | Sell |
21,269
-50
| -0.2% | -$7.37K | 0.36% | 77 |
|
|
2016
Q3 | $3.39M | Hold |
21,319
| – | – | 0.41% | 74 |
|
|
2016
Q2 | $3.15M | Sell |
21,319
-300
| -1% | -$44.3K | 0.39% | 77 |
|
|
2016
Q1 | $3.06M | Buy |
21,619
+2,800
| +15% | +$375K | 0.38% | 76 |
|
|
2015
Q4 | $2.67M | Hold |
18,819
| – | – | 0.35% | 80 |
|
|
2015
Q3 | $2.3M | Sell |
18,819
-912
| -5% | -$119K | 0.32% | 80 |
|
|
2015
Q2 | $2.56M | Sell |
19,731
-850
| -4% | -$111K | 0.32% | 79 |
|
|
2015
Q1 | $2.76M | Sell |
20,581
-175
| -0.8% | -$22.6K | 0.35% | 77 |
|
|
2014
Q4 | $2.6M | Hold |
20,756
| – | – | 0.32% | 80 |
|
|
2014
Q3 | $2.53M | Hold |
20,756
| – | – | 0.32% | 78 |
|
|
2014
Q2 | $2.45M | Hold |
20,756
| – | – | 0.3% | 80 |
|
|
2014
Q1 | $2.5M | Hold |
20,756
| – | – | 0.32% | 78 |
|
|
2013
Q4 | $2.31M | Buy |
20,756
+48
| +0.2% | +$4.77K | 0.3% | 79 |
|
|
2013
Q3 | $1.91M | Sell |
20,708
-232
| -1% | -$21K | 0.27% | 82 |
|
|
2013
Q2 | $1.77M | Buy |
+20,940
| New | +$1.74M | 0.26% | 83 |
|
Other funds holding TMO
VCM
Tower Bridge Advisors's TMO Position: Q1 2026 in Review
Tower Bridge Advisors increased its Thermo Fisher Scientific (TMO) stake by 4.1% in Q1 2026, buying an estimated $583K and bringing the position to 27,200 shares worth $13.4M. The position accounts for 1.29% of the portfolio, ranked #19.
Tower Bridge Advisors first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $32.2M in Q4 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Tower Bridge Advisors held 27,200 shares of Thermo Fisher Scientific worth $13.4M as of Q1 2026.
- Tower Bridge Advisors bought 1,075 Thermo Fisher Scientific shares in Q1 2026, an estimated $583K.
- Thermo Fisher Scientific made up 1.29% of Tower Bridge Advisors's portfolio in Q1 2026, its #19 holding.
- Tower Bridge Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Tower Bridge Advisors's Thermo Fisher Scientific position peaked at $32.2M in Q4 2021.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Tower Bridge Advisors's 13F filing for Q1 2026, filed 12 May 2026.